Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601031 | 0.92 | CYP17A1 (0.37) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 | |
| SCHEMBL25510116 | 0.92 | MEN1 (0.33) | ALDH1A1MEN1KMT2AATM | |
| SCHEMBL23817355 | 0.85 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 | |
| SCHEMBL19601025 | 0.84 | CYP17A1 (0.43) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 | |
| SCHEMBL25514964 | 0.81 | ALDH1A1 (0.32) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 | |
| SCHEMBL26151005 | 0.81 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 | |
| SCHEMBL21510901 | 0.80 | — | — | |
| SCHEMBL17548721 | 0.80 | MEN1 (0.33) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 | |
| SCHEMBL17550504 | 0.78 | MEN1 (0.30) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 | |
| SCHEMBL23817356 | 0.78 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2ACYP17A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180065924-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065924-A1 | SALT AND PHOTORESIST COMPOSITION CONTAINING THE SAME | C1R, RER1, C1S | ALDH1A1 2788/4885MEN1 1096/4885KMT2A 654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.